ProEncia Biotechnology
ProEncia Biotechnology

ProEncia Biotechnology

DR5Ahrefs DR: 5/100. Bottom 25%. Measured by Ahrefs. Median 44.Agent40Agent Readiness: 40/100. Below median. Measured by StartupHub.ai. Median 41.Speed40Site Speed: 40/100. Bottom 25%. Measured by Google PageSpeed. Median 62.

Developing next-generation, non-invasive periodontal disease treatments.

Website
2019Active5Minneapolis, USA

About

ProEncia Biotechnology is a biopharma startup focused on creating novel, non-invasive products for the treatment and commercialization of periodontal disease. Their pipeline aims to address patients suffering from periodontal disease at all stages of severity.

Key facts

At-a-glance profile data

Website
proenciabio.com
Headquarters
Minneapolis, Minnesota, USA
Founded
2019
Employees
5
Total funding
-
Business model
B2B2C

Funding rounds

Funding rounds raised by ProEncia Biotechnology
DateRoundAmountLead investors
19 May 2026Pre-SeedUndisclosed-

Tech stack

Detected on proenciabio.com, last scanned 25 Sept 2026. Run your own scan

CMS / Builders
Squarespace
Email provider
Google Workspace
Video / media
YouTube
Add first review

Frequently asked

How many employees does ProEncia Biotechnology have?

ProEncia Biotechnology has approximately 5 people on record.